Ranger Investment Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-200,342
Closed -$13.7M 81
2024
Q4
$13.7M Sell
200,342
-3,865
-2% -$269K 0.87% 46
2024
Q3
$14.7M Buy
204,207
+7,712
+4% +$544K 0.94% 42
2024
Q2
$13.6M Sell
196,495
-2,495
-1% -$182K 0.93% 47
2024
Q1
$15.9M Sell
198,990
-137,559
-41% -$12.3M 1.02% 45
2023
Q4
$36.9M Buy
336,549
+1,675
+0.5% +$173K 2.23% 12
2023
Q3
$33.8M Sell
334,874
-12,369
-4% -$1.42M 2.24% 12
2023
Q2
$47.2M Buy
347,243
+10,540
+3% +$1.29M 2.84% 7
2023
Q1
$35M Buy
336,703
+20,385
+6% +$1.97M 2.34% 18
2022
Q4
$28M Buy
316,318
+9,676
+3% +$803K 2.08% 17
2022
Q3
$24.6M Buy
306,642
+12,651
+4% +$1.19M 1.93% 20
2022
Q2
$28.2M Buy
293,991
+51,016
+21% +$6.12M 2.13% 17
2022
Q1
$36.1M Buy
242,975
+6,210
+3% +$867K 2.28% 15
2021
Q4
$33.6M Sell
236,765
-17,024
-7% -$2.41M 1.83% 21
2021
Q3
$33.2M Sell
253,789
-6,735
-3% -$881K 1.77% 24
2021
Q2
$35.8M Sell
260,524
-6,065
-2% -$830K 1.87% 20
2021
Q1
$34.8M Sell
266,589
-28,075
-10% -$3.38M 1.92% 21
2020
Q4
$33M Sell
294,664
-10,050
-3% -$952K 1.74% 28
2020
Q3
$24M Buy
304,714
+57,031
+23% +$4.65M 1.53% 29
2020
Q2
$17.8M Sell
247,683
-58,063
-19% -$4.04M 1.22% 37
2020
Q1
$17.5M Buy
305,746
+93,441
+44% +$8.62M 1.54% 28
2019
Q4
$23.7M Buy
212,305
+97,562
+85% +$10.4M 1.57% 28
2019
Q3
$11M Buy
+114,743
New +$10.8M 0.79% 49

Other funds holding CNMD

Ranger Investment Management's CNMD Position: Q1 2025 in Review

Ranger Investment Management sold out of CONMED (CNMD) in Q1 2025, closing a stake of 200,342 shares — an estimated $13.7M sold.

Ranger Investment Management first reported a position in CNMD in Q3 2019 and held it in 22 quarters. The position peaked at $47.2M in Q2 2023. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

  • Ranger Investment Management reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
  • Ranger Investment Management sold 200,342 CONMED shares in Q1 2025, an estimated $13.7M.
  • Ranger Investment Management first reported a position in CONMED in Q3 2019 and held it in 22 quarters.
  • Ranger Investment Management's CONMED position peaked at $47.2M in Q2 2023.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on Ranger Investment Management's 13F filing for Q1 2025, filed 15 May 2025.